Here are the seven latest medical devices or drugs approved by the Food and Drug Administration.
- Tecnis Symfony Introcular Lenses are intended for the treatment of cataracts.
- Hydromorphone HCI tablets are a new opioid treatment for patients with moderate to severe acute pain.
- Relistor, a treatment for opioid-induced constipation, is now available in tablet form.
- UltraShape Power is a new non-invasive fat destruction device.
- Belviq XR tablets are intended to help patients achieve and maintain weight loss when paired with a healthy diet and physical activity.
- Eight different generic versions of the cholesterol-lowering drug rosuvastatin will enter the market to compete with London-based AstraZeneca's brand name drug Crestor.
- Nilutamide tablets treat metastatic prostate cancer when used in combination with surgical castration.
More articles on supply chain:
Patients expect discounts for soaring drug costs: 3 things to know
Supply chain tip of the week: Don't underestimate the power of tidbits and newsletters
Jury finds former J&J executives guilty of illegal marketing for medical devices